Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Gynaecological Cancers Congress 2024

20 - 22 Jun 2024

Florence, Italy

ESMO-Gynaecological-Cancers-Congress-2024-1000x1000

Abstracts and ePosters: Open Access
Slides and Webcasts: Available to ESMO Members and registered delegates, subject to presenters' consent 

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third partiesESMO thanks the authors for their generosity.

The ESMO Gynaecological Cancers Congress 2024 provides insights into the diagnosis, biology and therapy of gynaecological malignancies, and updates on state-of-the-art expert management of patients with gynaecological cancers. The programme content highlights the scientific advances in profiling, risk stratification and innovative therapies for optimal care of these patients, with a focus on established and emerging biomarkers applicable for precision medicine and treatment selection.

All the resources are published!

Use the search box below to type any keywords, or the abstract number.

ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options

Slides and Webcasts

Hide
Filter by:

There are 134 resources available

Welcome by the Chairs

Presenter: All Speakers

Session: Welcome by the Chairs

Resources:

Slides

Webcast

Patients with dMMR and POLE mutation EC

Presenter: Ana Oaknin

Session: Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Resources:

Slides

Webcast

Patients with p53mut EC

Presenter: Stephanie Lheureux

Session: Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Resources:

Slides

Webcast

Patients with NSMP EC

Presenter: Mansoor Raza Mirza

Session: Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Resources:

Slides

Webcast

Q&A and discussion

Session: Tailoring first-line therapy in endometrial cancer (EC) according to the molecular classification

Resources:

Webcast

HRD and non-HRD

Presenter: Ilaria Colombo

Session: Is there a shift in the first-line treatment of ovarian cancer?

Resources:

Slides

Webcast

Q&A and discussion

Session: Is there a shift in the first-line treatment of ovarian cancer?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.